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INFLUENCE OF STEROIDS ON FIBROBLASTS. II. THE
FIBROBLAST AS AN ASSAY SYSTEM FOR TOPICAL
ANTI-INFLAMMATORY POTENCY OF
CORTICOSTEROIDS*
ANN G. RTJHMANN, M.D. AND DAVID L. BERLINER, M.D.t
Increasing experimental evidence points to
cortisol in contradistinction to cortisone, as a
potent anti-inflammatory agent (1—3). Studies
involving closely related compounds differing
only in the oxygen function at the 11-position
have indicated that this position is of prime
importance in the suppression of fibroblast
growth (4—6), and that in this situation also,
steroids with the 11/i-OH configuration are the
active ones. Moreover, the homologous 11-
desoxy compounds not only are fibroblast in-
hibitors of intermediate strength in vitro
(4), but also in vivo (7). Since the cellular
composition of connective tissue is over 90%
fibroblasts, it is not too surprising that in-
flammatory responses and fibroblast responses
parallel one another. That the action of fibro-
blasts in an isolated tissue culture system can
also be correlated to inflammatory responses
(8) is a fortunate occurrence for studying
basic tissue-steroid interactions.
The sensitivity of the tissue culture fibro-
blast to naturally occurring and synthetic
steroids is a consistent, measurable phenome-
non (4, 5, 9—11) ; in fact, it is considered a
most sensitive target cell (12, 13) for steroids.
in other studies (14), it has been shown that
different tissue culture cell types respond in a
variety of ways to the same steroid. Certain
positions on the corticosteroid molecule, of
which the 11-position is but one, have long
been known to be of critical importance for
topical anti-inflammatory activity (2, 7, 15,
16). It is now also known that protecting or
potentiating these key structures by addition
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of various substitutions to the steroid mole-
cule enhances its topical antiphlogistic ac-
tivity (2, 15, 16).
The data presented here are correlations be-
tween growth inhibition by steroids in a tis-
sue culture fibroblast test and topical anti-
inflammatory activity.
MATERIALS AND METHODS
Murine fibroblasts (929-L) were grown as mono-
layers in Eagle's minimum essential medium (17)
(Earle's balanced salt solution), containing 2 mM
glutamine, 10% calf serum, penicillin (100 U/mi)
and streptomycin (0.1 mg/ml). Roller tubes 18 X
150 mm, containing 5 ml of media, were inoculated
on day zero of the experimental period with 100,-
000 cells. Following a 24 hour stationary phase to
allow cell attachment to glass surfaces, the tubes
were rotated four days at '/5 revolution per min-
ute. On day five, cells were scraped free of the
glass by rubber policemen, mixed 10 times in an
automatic syringe, and diluted to give cell suspen-
sions of convenient concentration for counting.
Details of the method are described in a previous
paper (20).
The initial cell inoculation was made into
media containing either 1 sL/ml of propylene
glycol (control) or steroid dissolved in 1 sL/ml of
propylene glycol. Purified steroid was weighed and
diluted with absolute methanol to a concentration
of 100 sg/ml. Appropriate aliquots of this solution
or 100- or 1000-fold dilutions of it were added to a
propylene glycol-methanol mixture in 8 ounce
prescription bottles. The methanol was evaporated
under a nitrogen stream so that a final, water solu-
ble steriod solution was assured in the propylene
glycol culture medium.
Determinations of number of cells per roller
tube were performed in an electronic cell counter
adjusted to count all particles larger than 975 s.
Five tubes were utilized to determine each point,
and the resulting data subjected to statistical
analysis by means of analysis of variance and re-
gression calculations (18, 19). Logarithmically
transformed data were graphed as average number
of cells per tube on the ordinate, against steroid
dose as the abscissa. Relative potencies were cal-
culated for the compounds tested, based on an
assigned potency of one for cortisol. Criteria for
statistical accuracy were thoroughly checked (20).
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The index of significance (g) varied between 0.004
and 0.01, indicating significant slope regression for
all fibroblast inhibiting steroids. Indices of pre-
cision (X) varied between 0.11 and 0.39, but the
vast majority were below 0.2 (20). Therefore, the
variability witbin the experimental method was
extremely small. Moreover, all experiments were
repeated at least once, with good reproducibility
of potency ratios obtained.
RESULTS
The steroid vehicle, propylene glycol, was
tested for effects on cell growth at a number
of concentrations. At 1 [LL/ml, the concentra-
tion used in the experiments, there was no
inhibition of cell growth. These experiments
are reported in detail in other publications
(5, 20).
Figure 1 is a composite of two experiments
illustrating the effect on fibroblast growth of
the closely related compounds cortisone (11-
keto), cortisol (11$-OH), and il-desoxycorti-
sol. The logarithmic abscissa represents dose
of steroid, the ordinate millions of cells per
tube with each point based on an average of
5 tubes. The lines connect actual points (for
easier visualization), and are not the fitted
lines obtained by calculation. Cortisol is an
inhibitor of fibroblast growth at 0.1, 0.5, and
1.0 pg/ml (approximately 3 x 10 to 3 x
10 xi) of medium. Cortisone, on the other
band, does not inhibit fibroblasts in vitro,
and has a stimulatory effect at all concentra-
tions tested. However, only at 1.0 ig/ml is
this statistically significant. The compound
of the set which has no oxygen at position C-
11 is intermediate in action between the other
two compounds.
Figure 2 is a similar representation in an
experiment involving 1 1-dchydrocorticosterone
(ketone at C-il), corticosterone ($-OH at C-
11), and li-desoxycorticosterone. Again, the
compound containing a ketone at position C-
11 does not inhibit the growth of tissue cul-
ture fibroblasts except at the highest concen-
tration, whereas the 11$-OH compound is the
most potent of the set, and the compound
without an 11-oxygen function is intermediate
in action. Similar results were found in ex-
periments using 2-methylcortisone and 2-
methylcortisol, as well as with prednisone and
prednisolone (4).
Figure 3 illustrates the dose-response curves
obtained when tissue culture fibroblasts arc incu-
bated with the synthetic compoimds li-desoxy-
fiurandrenolone (6a-fiuoro 16a, 17a ,21-trihy-
droxy-pregn-4-ene-3, 20-dionc-16, 17-acetonide)
and il-desoxy, 21-desoxyfiurandrenolone (6a-
fluoro 16a, 17a-dihydroxy pregn-4-ene-3 ,20
dione, 16, 17-acetonide). By referring to cortisol
as a standard, it is apparent that both com-
pounds are active fibroblast inhibitors, but 11-
desoxyfiurandrenolone is the more potent.
Figure 4 is a graphic representation of the
actions of paramethasone acetate (6a-fiuoro
16a-methyl-1l$, 17a ,21-trihydroxy, pregna-1 , 4-
diene 3, 20-dione 21-acetate) and fiumethasone
acetate (6a ,9a-difiuoro, 16a-methyl-1 1$, 17a,
21-trihydroxy prcgna-1 ,4-diene 3, 20-dione 21-
Fro. 1. Two cycle semilogarithmic plot showing action of cortisone, 11-desoxycortisol, and
cortisol on fibroblast growth. Millions of cells, based on an average from five tubes per point,
are plotted on the ordinate against steroid concentration on the abscissa.
Fio. 2. Two cycle semilogarithmic plot showing action of 11-dehydrocorticosterone, 11-
desoxycorticosterone, and corticosterone on fibroblast growth. Millions of cells, based on an
average from five tubes per point, are plotted on the ordinate against steroid concentration
on the abscissa.
. .
FIG. 3. Three cycle semilogarithmic plot showing action of cortisol, li-desoxy, 21-desoxy-
flurandrenolone, and 11-desoxyfiurandrenolone on fibroblast growth. Millions of cells, based
on an average from five tubes per point, are plotted on the ordinate against steroid concen-
tration on the abscissa.
FIG. 4. Three cycle semilogarithmic plot showing action of fiumethasone acetate and
paramethasone acetate on fibroblast growth. Millions of cells, based on an average from five
tubes per point, are plotted on the ordinate against steroid concentration on the abscissa.
Fio. 5. Two cycle semilogarithmic plot showing action of cortisol, paramethasone and
tetrahydrotriamcinolone acetonide on fibroblast growth. Millions of cells, based on an aver-
age from five tubes per point, are plotted on the ordinate against steroid concentration on
the abscissa.
FIG. 6. Four cycle semilogarithmic plot showing action of dichlorisone, dichlorisone 16,17-
acetonide, and cortisol on fibroblast growth. Millions of cells, based on an average from five
tubes per point, are plotted on the ordinate against steroid concentration on the abscissa.
FIG. 7. Four cycle semilogarithmic plot showing action of cortisol and fiuocinolone aceto-
nide on fibroblast growth. Millions of cells, based on an average from five tubes per point,
are plotted on the ordinate against steroid concentration on the abscissa.
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acetate) on the fibroblast. Flumethasome ace-
tate markedly depresses growth at 0.01 (3 x
10 M) and 0.1 g/m1 (3 x 10 M), while
the other compound is active at 0.1 and 1.0
jzg/ml. It has been our experience that a
steroid and its acetate behave in a similar
fashion in the tissue culture fibroblast assay
because of the presence of an acylase in this
system. In Figure 5 the relationship between
paramethasone and tetrahydrotriamcinolone
acetonide (9a-fluoro 11/3, 16a, 17a,21-tetra-
hydroxy allopregnan 3, 20-dione 16, 17-aceto-
nide) is seen as that of a weaker to a more
potent compound, but both are far more po-
tent than cortisol.
In Figure 6, the potencies of two different
9,1 1-dichloro steroids are depicted. Dichlori-
sone acetate (9a, 11/3-dichloro-17a , 21-dihy-
droxypregna 1, 4-diene ,3,20-dione 21-acetate)
and dichlorisone 16, 17-acetonide are more ac-
tive than cortisol, but the 16,17-acetonide
steroid inhibits fibroblast growth at a con-
centration of 0.001 g/m1 (3 x l0 M).
In Figure 7, the potency of fluocinolone
acetonide (6a ,9a-difluoro 11/3, lGa, 17a ,21-tet-
rahydroxy pregna 1, 4-diene 3, 20-dione 16,17-
acetonide) is well illustrated. This compound
significantly inhibits fibroblast growth at a
concentration of 0.001 g/ml (3 x 10° M) and
is several hundred times as powerful as cortisol
in this activity. In separate experiments,
fluocinolone acetonide has markedly inhibited
fibroblast growth at a concentration of 0.00075
tg/m1 and moderately inhibited it at 0.0005
g/ml (approximately 10° M). The structural
formulae of all the steroids tested and their
potency ratios are presented in Table I.
CONCLU5IONS
The compounds presented in Table I are
depicted in order of increasing strength as
fibroblast inhibitors. Corticostcrone has a rel-
ative potency of 0.48 when compared to corti-
sol. The diminished fibroblast inhibition
demonstrated by corticosterone is due to its
lack of an a-OH group at the C-17 position,
such as is possessed by cortisol. The im-
portance of the 11-position, however, is over-
riding, as can be seen in the case of cortisone,
which exhibits no fibroblast inhibition, de-
spite the 17a-hydroxyl group. A ketone at
position C-il completely blocks the growth
depressing effect of the steroid and, in fact,
can confer a growth enhancing potential (4)
on the molecule, as is the case with cortisone.
It is known that this steroid, when paren-
terally administered, has anti-inflammatory
activity only when it cart be transformed to
cortisol (3). In the tissue culture system under
discussion, the biotransformation of cortisol
and cortisone (11/3-OH dehydrogenase sys-
tem) is minimal (4), and that is the reason
for the dichotomy between the in viva and
in vitro activities of cortisone. In dermatologi-
cal practice also, topical cortisone is disap-
pointingly devoid of anti-inflammatory ac-
tivity (2, 25).
The fourth compound listed in Table I,
prednisolone, differs from cortisol only in the
presence of an additional double bond in ring
A between C-i and C-2. Its fibroblast in-
hibiting potency is essentially the same as
that of cortisol. The table shows the relative
potencics of these compou:ads measured by the
fibroblast assay method, as well as their relative
potencies with other assays. The oral potency of
prednisolone is about 4 times that of cortisol
(26). In contrast, however, topical activity is
only one or two times that of cortisol (2, 27).
Here again, as in the case of cortisone, the
agreement between steroidal topical anti-in-
flammatory activity and the fibroblast assay,
is very close.
Dexamethasone is 7.5 times more potent in
suppressing fibroblast growth than cortisol or
prednisolone. This characteristic is attrib-
uted to the addition of a 9a-fluoro and a 16a-
methyl substitution to the molecule. Dexa-
methasone has been found highly effective
orally as an anti-inflammatory agent (26). It
is interesting to note that of all of the assays
listed, only the tissue culture fibroblast system
finds a potency for dexamethasone which is
comparable to topical clinical trial (2, 28, 29).
Paramethasone differs from dexamethasone in
the position of the a-fluorine group. Para-
methasonc, with the a-fluorine at position 6,
is somewhat more potent than dexamethasone.
Reference to the lower part of the table
shows that the 16, 17-acetonide group is a
potent enhancer of fibroblast inhibitory ac-
tivity to the steroid molecule. Yet il-des-
oxyflurandrenolone, which possesses this sub-
stituent, is less potent than paramethasone.
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The reason for this can be found in the 11- except for an additional double bond in ring
position. As was seen in Figures 1 and 2, the A and chlorine substitutions at positions C-
absence of the 11/3-OH causes a marked loss of 9 and C-li, has a potency in the same range
fibroblast growth depression. in the fibroblast assay as paramethasone and
Dichlorisone, which is similar to cortisol dexamethasone. In the thymolytic and anti-
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granulomatous assays, its activity is the same
or less than that of cortisol (30). Tolksdorf
refers to data which indicates that diehlori-
sone has topical anti-inflammatory activity
higher than prednisolone in humans (30).
Tetrahydrotriamcinolone acetonide, a ste-
roid in which both double bonds at C-i ,2 and
C-4 ,5 are reduced, leaving a 3-ketone,
configuration in ring A, surprisingly enough
possesses flbroblast inhibiting capacities. This
is the first instance in which we have found
a steroid which is reduced in ring A, with
any activity (5). Compared to 11-desoxy-
flurandrenolone, it is approximately twice as
potent, further indicating that the 11/3-011
group is crucial to the fibroblast inhibiting
activity of the steroid molecule. The presence
of a 16, 17-acetonide structure in these fluori-
nated steroids can override the diminished
potency secondary to reduction in ring A.
Diehlorisone 16, 17-acetonide, which is also
a 9a,11/3-chlorinated steroid, has a potency
ratio of 43.7 by the fibroblast assay (Table I).
This compound has been shown to be less
active than eortisol in the thymolytic test
(16), but 23.2 times as potent as eortisol by a
topical antiphlogistic test (16). The paren-
teral-topical discrepancy for these two 9,11-
diehloro steroids is dramatic. However, their
potency by the flbroblast assay is very similar
to their topical anti-inflammatory activity.
Triameinolone aeetonide possesses only one
fluorine group, hut it also has one of the most
potent functional groups, the 16, 17-aeetonide,
which confers upon it a potency of 156 times
that of cortisol.
The strongest fibroblast growth suppressant
tested by us to date, and also the most potent
topical anti-inflammatory agent (2, 23, 24) is
fluoeinolone aeetonide. This compound causes
consistent, profound depression of fibroblasts
at extremely low concentrations (5) (see Fig.
6) and has a relative potency of 440 when
compared to cortisol.
The presence of a 16, 17-acetonide confers on
the steroid molecule a high degree of fibro-
blast inhibition, and topical anti-inflamma-
tory potency. This is well illustrated by ref-
erence to the potency ratios of three sets of
compounds differing only in the absence of a
16, 17-aeetonide structure. Thus, dexametha-
sone has a relative potency of 7.5, while
triameinolone acetonide has a potency of 156.
Likewise, dichlorisone and dichlorisone 16,17-
acetonide have potency ratios of 14.2 and 43.7,
respectively. Finally, fluocinolone acetonide is
22 times more potent as a flbroblast inhibitor
than flumethasone (P.R. =20).
All the naturally occurring steroids tested
by the fibroblast inhibition assay method
were used in concentrations well within phys-
iological limits. By extrapolating from the
relative potency data, it is possible to recog-
nize that the synthetic steroids are in the
same concentration range. Hence, one of the
criticized shortcomings of in vitro testing
31) is eliminated; namely, that concentra-
tions used are of such toxic proportions that
they can give no information concerning in
vivo action. The thymus involution and anti-
granulomatous assays have always been useful
for general evaluation of eortieosteroid ac-
tivity. However, they do not always correlate
well with topical potency. Moreover, as can be
seen by reference to Table I, the findings of
the fibroblast assay method are in excellent
agreement with clinical findings of topical
anti-inflammatory activity. The method,
therefore, can be an extremely useful addition
to the bioassays available for preelinieal trial
purposes.
The need for a test that correlates well with
topical anti-inflammatory activity is further
illustrated in the ease of another steroid, 16a,
17a - dihydroxyprogesterone - 16,17 - aeetonide,
which has been shown by Bronstein et al.
32) to be without efficacy in treating human
skin inflammations, despite strong potency by
several animal antigranuloma assays. In the
fibroblast assay also, this compound is without
significant inhibitory activity within phys-
iological concentrations. However, the addi-
tion of a fluorine at position-6 confers fibro-
blast inhibitory activity on this compound,
as can be seen in Figure 3.
It is in the elucidation of structure-activity
relationships that the fibroblast assay is of
greatest utility. It is apparent from the data
presented in this paper that an interdependent
hierarchy of functional groups exists. Steroids
require 17a- and 21-hydroxyl groups for en-
hanced topical anti-inflammatory activity.
However, the 11-position plays a role that is
vital. A fl-OH group at the C-il position
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gives fibroblast inhibition of marked potency,
and the mere removal of two hydrogens at
this position destroys the inherent inhibitory
action of the entire molecule. In the synthetics,
the situation is more complex, but it can be
said that added 6(1- and 9a-fluorines, and
formation of 16, 17-acetonides are the methods
of conferring increasing fibroblast growth in-
hibitory action on the steroid nucleus.
SUMMARY
A number of naturally occurring and syn-
thetic steroids were tested for fibroblast in-
hibiting potency in a tissue culture system. It
was found that the , 3-ketone, 21-hydroxyl,
and 1 1f3-hydroxyl groups are necessary to the
steroid nucleus for insuring fibroblast inhibi-
tion. The 17a-OH group is also of importance
in this regard. Increasing steroidal fibroblast
depression is attained by addition of complex
substituents such as Ga- and 9a-fluorincs, and
presence of a 16, 17-acctonide structure on the
steroid molecule.
Fibroblast inhibiting potency and topical
anti-inflammatory activity are possessed by
9,1 1/3-dichloro compounds, despite their lack
of potency in anti-granuloma and tbymus in-
volution tests. Comparison of steroid potency
measured by this test and by other laboratory
procedures to topical anti-inflammatory ac-
tivity manifest by clinical trial, indicated
that the tissue culture assay is an excellent
addition to the bioassay systems available.
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